Trials / Completed
CompletedNCT02512588
A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Balance Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, placebo-controlled, double-blind, multiple cohort, fixed-dose multiple crossover, dose-finding study of oral BTD-001 in adult patients with IH or Narcolepsy without cataplexy (Type 2).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BTD-001 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2015-07-31
- Last updated
- 2019-01-16
Locations
23 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02512588. Inclusion in this directory is not an endorsement.